Experimental Treatments / Integrase Inhibitors

Two Novel Fusion Inhibitors Demonstrate In Vitro Activity against HIV - 8/29/06

Preliminary Antiviral Activity and Safety of Experimental PI Brecanavir/ritonavir (BCV/r) - 8/25/06

Cross-resistance Profile of Experimental PI Brecanavir - 8/25/06

Pharmacokinetics and Safety of New NRTI Fosalvudine Tidoxil - 8/25/06

TNX-355 Produces Significant Reduction in HIV Viral Load at 48 Weeks - 8/25/06

MK-0518 Integrase Inhibitor Is Active Against HIV through Week 24  - 8/22/06